当前位置:首页 - 行情中心 - 美康生物(300439) - 财务分析 - 资产负债表

美康生物

(300439)

  

流通市值:29.73亿  总市值:39.12亿
流通股本:2.92亿   总股本:3.84亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金809,335,968.51958,881,876.13929,317,475.8917,447,281.23
应收票据及应收账款577,477,026.43567,720,759.28681,622,586.06688,230,829.94
其中:应收票据3,800,000-1,064,254.28712,754.28
应收账款573,677,026.43567,720,759.28680,558,331.78687,518,075.66
应收款项融资700,0002,200,0001,500,000-
预付款项43,220,656.444,410,140.1482,892,429.0266,713,955.27
其他应收款合计28,874,205.0836,324,036.1557,066,098.5365,901,066.44
应收股利--8,774,088.685,823,185.68
存货234,758,333.41259,010,013.51221,855,670.63208,239,921.32
其他流动资产26,602,849.324,618,716.8820,240,156.932,425,781.77
流动资产平衡项目0000
流动资产合计1,791,170,239.131,899,165,542.091,994,494,416.971,948,958,835.97
非流动资产:
长期股权投资162,238,366.37155,942,991.95170,563,832.27164,720,512.81
其他权益工具投资5,000,0005,000,00010,461,213.2410,461,213.24
投资性房地产--99,705,227.01100,439,638.02
固定资产962,788,212.03981,583,751.96901,032,882.64789,610,165.24
在建工程240,339,936.43160,501,656.6170,919,296.47272,758,011.32
使用权资产31,938,025.3436,218,805.8432,284,533.536,975,695.34
无形资产125,473,102.75127,847,100.31112,176,971.19113,817,735.44
长期待摊费用28,792,764.0434,342,037.1528,022,963.6314,090,931.19
递延所得税资产36,386,059.6935,530,610.3929,798,763.3933,359,689.82
其他非流动资产56,073,416.9853,053,441.712,282,608.3835,817,107.56
非流动资产平衡项目0000
非流动资产合计1,649,029,883.631,590,020,395.91,567,248,291.721,572,050,699.98
资产平衡项目0000
资产总计3,440,200,122.763,489,185,937.993,561,742,708.693,521,009,535.95
流动负债:
短期借款30,022,083.3350,053,733.33120,095,069.44120,081,319.44
应付票据及应付账款319,810,952.03333,462,927.37341,833,266.93375,403,974.97
其中:应付票据35,000,00015,000,00025,000,00035,000,000
应付账款284,810,952.03318,462,927.37316,833,266.93340,403,974.97
合同负债50,378,404.688,269,591.0868,151,347.1566,177,686.21
应付职工薪酬45,972,509.298,866,292.6499,385,781.8366,740,282.18
应交税费32,640,20527,099,725.4148,453,529.1132,381,437.59
其他应付款合计74,084,895.6571,773,367.0986,242,842.25101,112,912.82
应付股利---16,883,427.11
一年内到期的非流动负债17,459,388.1719,521,788.0934,114,313.0246,579,094.47
其他流动负债6,183,700.5510,081,520.378,839,171.038,582,595.11
流动负债平衡项目0000
流动负债合计576,552,138.53699,128,945.38807,115,320.76817,059,302.79
非流动负债:
租赁负债19,699,917.3223,595,973.3319,824,936.6521,817,699.38
预计负债-1,448,971.3211,619,875.411,619,875.4
递延收益10,672,0009,898,666.673,804,5003,842,000
递延所得税负债47,156,934.1348,420,487.4141,410,617.8638,690,577.48
非流动负债平衡项目0000
非流动负债合计77,528,851.4583,364,098.7376,659,929.9175,970,152.26
负债平衡项目0000
负债合计654,080,989.98782,493,044.11883,775,250.67893,029,455.05
所有者权益(或股东权益):
实收资本(或股本)383,949,815382,999,815382,999,815382,999,815
资本公积1,115,611,094.21,109,299,549.741,115,521,662.811,116,761,560.94
减:库存股5,907,940.75---
其他综合收益-29,114,501.99-29,136,845.46-24,893,077.69-24,878,426.57
盈余公积121,181,021.44121,181,021.44121,181,021.44121,181,021.44
未分配利润1,209,687,133.431,130,590,362.231,103,551,700.931,048,460,806.6
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,795,406,621.332,714,933,902.952,698,361,122.492,644,524,777.41
少数股东权益-9,287,488.55-8,241,009.07-20,393,664.47-16,544,696.51
股东权益平衡项目0000
股东权益合计2,786,119,132.782,706,692,893.882,677,967,458.022,627,980,080.9
负债和股东权益合计3,440,200,122.763,489,185,937.993,561,742,708.693,521,009,535.95
公告日期2024-04-242024-04-192023-10-262023-08-19
审计意见(境内)标准无保留意见
TOP↑